A detailed history of Blume Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Blume Capital Management, Inc. holds 65,031 shares of JNJ stock, worth $9.43 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
65,031
Previous 65,159 0.2%
Holding current value
$9.43 Million
Previous $9.52 Million 10.66%
% of portfolio
2.44%
Previous 2.35%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$145.48 - $167.38 $18,621 - $21,424
-128 Reduced 0.2%
65,031 $10.5 Million
Q2 2024

Aug 05, 2024

BUY
$144.38 - $157.78 $850,975 - $929,955
5,894 Added 9.95%
65,159 $9.52 Million
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $232,830 - $244,110
1,500 Added 2.6%
59,265 $9.38 Million
Q4 2023

May 01, 2024

BUY
$145.6 - $158.88 $144,435 - $157,608
992 Added 1.75%
57,765 $9.05 Million
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $144,435 - $157,608
992 Added 1.75%
57,765 $9.05 Million
Q3 2023

May 01, 2024

SELL
$155.75 - $174.48 $114,943 - $128,766
-738 Reduced 1.28%
56,773 $8.84 Million
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $114,943 - $128,766
-738 Reduced 1.28%
56,773 $8.84 Million
Q2 2023

May 01, 2024

BUY
$154.35 - $166.11 $916,530 - $986,361
5,938 Added 11.51%
57,511 $9.52 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $916,530 - $986,361
5,938 Added 11.51%
57,511 $9.52 Million
Q1 2023

May 01, 2024

SELL
$151.05 - $180.26 $935,301 - $1.12 Million
-6,192 Reduced 10.72%
51,573 $7.99 Million
Q1 2023

May 08, 2023

BUY
$151.05 - $180.26 $1.13 Million - $1.35 Million
7,493 Added 17.0%
51,573 $7.99 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $112,139 - $125,853
-700 Reduced 1.56%
44,080 $7.79 Million
Q3 2022

Nov 15, 2022

SELL
$161.33 - $179.52 $39,041 - $43,443
-242 Reduced 0.54%
44,780 $7.32 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $1.85 Million - $2.04 Million
-10,994 Reduced 19.63%
45,022 $7.99 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $79,386 - $90,154
-502 Reduced 0.89%
56,016 $9.93 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $106,967 - $118,684
686 Added 1.23%
56,518 $9.67 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $39,567 - $43,970
-245 Reduced 0.44%
55,832 $9.02 Million
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $339,213 - $363,865
2,127 Added 3.94%
56,077 $9.24 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $242,769 - $270,381
1,586 Added 3.03%
53,950 $8.87 Million
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $108,728 - $124,802
-793 Reduced 1.49%
52,364 $8.24 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $3,930 - $4,307
-28 Reduced 0.05%
53,157 $7.91 Million
Q2 2020

Aug 06, 2020

SELL
$128.81 - $155.51 $133,833 - $161,574
-1,039 Reduced 1.92%
53,185 $7.48 Million
Q1 2020

May 07, 2020

SELL
$111.14 - $153.99 $111,140 - $153,990
-1,000 Reduced 1.81%
54,224 $7.11 Million
Q4 2019

Feb 05, 2020

SELL
$127.5 - $146.44 $558,450 - $641,407
-4,380 Reduced 7.35%
55,224 $8.06 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $112,731 - $126,220
888 Added 1.51%
59,604 $7.71 Million
Q2 2019

Jul 29, 2019

SELL
$131.15 - $144.24 $53,771 - $59,138
-410 Reduced 0.69%
58,716 $8.18 Million
Q1 2019

May 06, 2019

SELL
$125.72 - $139.79 $43,750 - $48,646
-348 Reduced 0.59%
59,126 $8.27 Million
Q4 2018

Feb 05, 2019

SELL
$122.84 - $147.84 $185,611 - $223,386
-1,511 Reduced 2.48%
59,474 $7.68 Million
Q3 2018

Nov 02, 2018

BUY
$121.58 - $142.88 $62,248 - $73,154
512 Added 0.85%
60,985 $8.43 Million
Q2 2018

Aug 02, 2018

BUY
$119.4 - $131.76 $99,102 - $109,360
830 Added 1.39%
60,473 $7.34 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $606,484 - $718,182
-4,848 Reduced 7.52%
59,643 $7.64 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $507,558 - $555,522
-3,868 Reduced 5.66%
64,491 $9.01 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $8.85 Million - $9.25 Million
68,359
68,359 $8.89 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Blume Capital Management, Inc. Portfolio

Follow Blume Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blume Capital Management, Inc. with notifications on news.